Success Metrics

Clinical Success Rate
90.8%

Based on 79 completed trials

Completion Rate
91%(79/87)
Active Trials
8(7%)
Results Posted
56%(44 trials)
Terminated
8(7%)

Phase Distribution

Ph phase_1
4
4%
Ph phase_2
24
22%
Ph phase_4
36
33%
Ph phase_3
24
22%
Ph not_applicable
12
11%

Phase Distribution

4

Early Stage

24

Mid Stage

60

Late Stage

Phase Distribution100 total trials
Phase 1Safety & dosage
4(4.0%)
Phase 2Efficacy & side effects
24(24.0%)
Phase 3Large-scale testing
24(24.0%)
Phase 4Post-market surveillance
36(36.0%)
N/ANon-phased studies
12(12.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.8%

79 of 90 finished

Non-Completion Rate

12.2%

11 ended early

Currently Active

8

trials recruiting

Total Trials

109

all time

Status Distribution
Active(10)
Completed(79)
Terminated(11)
Other(9)

Detailed Status

Completed79
unknown8
Terminated8
Recruiting7
Withdrawn3
Enrolling by invitation2

Development Timeline

Analytics

Development Status

Total Trials
109
Active
8
Success Rate
90.8%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (4.0%)
Phase 224 (24.0%)
Phase 324 (24.0%)
Phase 436 (36.0%)
N/A12 (12.0%)

Trials by Status

unknown87%
withdrawn33%
completed7972%
active_not_recruiting11%
terminated87%
enrolling_by_invitation22%
suspended11%
recruiting76%

Recent Activity

Clinical Trials (109)

Showing 20 of 109 trialsScroll for more
NCT06558188Phase 4

Combined Anabolic Therapy

Recruiting
NCT06264609Phase 4

Precision Medicine Approach for Osteoporosis - Follow Up Study

Enrolling By Invitation
NCT05866029Not Applicable

Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

Recruiting
NCT01225055Phase 2

Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury

Completed
NCT07242612Not Applicable

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

Recruiting
NCT04669782Not Applicable

Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging

Terminated
NCT06164795

Sequential Therapies After Osteoanabolic Treatment

Recruiting
NCT05151484Phase 4

Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover

Recruiting
NCT03133195Phase 3

The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA

Completed
NCT03770338Not Applicable

Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

Recruiting
NCT04522622Phase 4

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease

Recruiting
NCT04974723

Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

Completed
NCT06061354Phase 4

Teriparatide on Maxillary Sinus Floor Osseointegration

Unknown
NCT04026256Phase 4

Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration

Completed
NCT04879420

Replication of the VERO Osteoporosis Trial in Healthcare Claims Data

Completed
NCT01155232

Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis

Unknown
NCT03072147Phase 2

Teriparatide as a Chondroregenerative Therapy in OA

Completed
NCT02025179Phase 2

12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)

Completed
NCT04589819Phase 4

Fracture Recovery for Returning to Duty (Teriparatide STRONG)

Enrolling By Invitation
NCT03472846Phase 4

MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis

Completed

Drug Details

Intervention Type
DRUG
Total Trials
109